Testosterone Doesn’t Just Convert to Estrogen. It Can Suppress It
What new human tissue data reveals about testosterone, estrogen signaling, and breast biology
The assumption most people get wrong
There’s a persistent belief in medicine and longevity circles that goes like this:
If you increase testosterone, you inevitably increase estrogen.
The logic seems straightforward. Testosterone can be converted into estradiol through aromatase, especially in fat tissue. So more testosterone should mean more estrogen activity.
But biology is rarely that simple.
A new study looking directly at human breast tissue challenges this assumption in a meaningful way.
Why this question matters now
Testosterone therapy is increasingly used across different populations:
Transgender men on long-term hormone therapy
Women receiving low-dose testosterone for specific indications
Men optimizing hormone levels for metabolic and performance goals
At the same time, concerns about estrogen exposure remain central to long-term risk, particularly in breast tissue.
So the key question becomes:
Does higher testosterone actually increase estrogen signaling where it matters?
What the researchers actually studied
This study used single-cell RNA sequencing to analyze breast tissue from two groups:
Cisgender women not on testosterone
Transgender men receiving testosterone therapy
As shown in Figure 1 (page 7), the researchers mapped over 24,000 individual cells across multiple tissue types, allowing them to see how specific cell populations respond to hormones.
Importantly, both groups had similar circulating estradiol levels.
So this was not a study of “low estrogen vs high estrogen.”
It was a study of what testosterone does on top of normal estrogen levels.
The key finding: estrogen signaling dropped
Despite similar estradiol levels in the blood, the effects inside the tissue were very different.
In hormone-sensitive breast cells, testosterone therapy was associated with:
Reduced expression of genes downstream of estrogen signaling
Lower activity of hormone-response pathways
Decreased progesterone receptor expression
This is a critical distinction.
Hormone levels in the bloodstream did not change significantly.
But the cellular response to estrogen did.
Where this effect happens
The strongest changes were seen in a specific cell type:
Hormone receptor positive luminal epithelial cells.
As highlighted in Figure 1E (page 7), these cells showed the greatest transcriptional changes with testosterone exposure.
These are the cells responsible for:
Sensing estrogen and progesterone
Coordinating tissue-level responses
Driving downstream signaling across the breast
When their signaling changes, the entire tissue environment shifts.
What actually decreased
Looking deeper into Figure 2 (page 8), several key estrogen-driven pathways were downregulated:
Amphiregulin (AREG), a direct mediator of estrogen signaling
WNT4 and RANKL, linked to progesterone-driven proliferation
PTHLH, a major developmental and signaling factor
At the protein level, this translated into:
A significant reduction in progesterone receptor expression (Figure 3, page 10)
This matters because progesterone receptor is a downstream marker of estrogen activity.
Lower PR expression reinforces the idea that estrogen signaling itself is being suppressed.
So what’s actually happening?
The key insight is this:
Testosterone is not just a precursor to estrogen.
It can act as a functional antagonist to estrogen signaling at the tissue level.
Even when estradiol levels remain normal, testosterone appears to:
Reduce activation of estrogen-responsive genes
Alter receptor signaling dynamics
Decrease downstream hormone responsiveness
In other words, hormone levels alone do not tell the full story.
What matters is how tissues respond.
What about aromatization?
One of the biggest concerns with testosterone therapy is aromatization.
The assumption is that more testosterone leads to more local estrogen production in tissues like the breast.
But this study did not support that concern.
Despite high testosterone exposure:
There was no increase in estrogen signaling
Instead, there was a consistent decrease
The authors suggest a few possible explanations:
Testosterone may directly suppress estrogen receptor signaling
High androgen levels may counteract local estrogen effects
Tissue-specific regulation may override simple hormone conversion
Importantly, these mechanisms are not fully resolved.
What this means clinically
This shifts how we think about hormones in a meaningful way.
It suggests that:
Serum hormone levels are not sufficient to understand tissue effects
Testosterone may have anti-estrogenic effects in certain contexts
Hormone interactions are highly tissue-specific
It also raises important considerations for:
Long-term hormone therapy
Breast cancer biology
Risk stratification in different patient populations
What this does not mean
It does not mean testosterone is universally protective.
The relationship between androgens and breast cancer is complex and context-dependent.
As the paper emphasizes:
Androgen signaling can have both protective and harmful effects depending on the setting
Data on long-term outcomes remains limited
Mechanisms are still being worked out
This is early, mechanistic insight. Not a clinical directive.
The deeper takeaway
This study highlights something fundamental in physiology:
Hormones are not just about levels.
They are about signaling.
Two people can have the same hormone levels in their blood and completely different biological responses at the tissue level.
That is where the real story is.
Closing perspective
For years, the conversation around testosterone and estrogen has been framed too simply.
More testosterone equals more estrogen.
But this data suggests something more nuanced.
In the right context, testosterone may actually dampen estrogen signaling where it matters most.
And that forces us to rethink how we interpret hormone biology in longevity and clinical care.
References
Phong, K. T., Song, S., Kim, E. A., Conrad, D. N., & Gartner, Z. J. (2026). Single cell RNA-sequencing reveals that testosterone reduces estrogen signaling in the healthy human mammary gland. Journal of Mammary Gland Biology and Neoplasia. https://doi.org/10.1007/s10911-026-09605-y